Genetic variability of pain perception and treatment—clinical pharmacological implications Jörn Lötsch Review Article 23 February 2011 Pages: 541 - 551
Combination therapy with diltiazem plus CsA/MMF/Pred or CsA/Aza/Pred triple immunosuppressive regimens for use in clinical kidney transplantation in Northwestern China Yong SongWujun XueXiaohu Fan Clinical Trial 29 January 2011 Pages: 553 - 562
Early phase drugs and biologicals clinical trials on worldwide leading causes of death: a descriptive analysis Rafael Dal-Ré Special Article 05 April 2011 Pages: 563 - 571
The influence of tocolytic drugs on cardiac function, large arteries, and resistance vessels Isabelle G. FabryPeter De PaepeLuc M. Van Bortel Pharmacodynamics 15 April 2011 Pages: 573 - 580
The influence of genetic polymorphisms and interacting drugs on initial response to warfarin in Chinese patients with heart valve replacement Shi-Long ZhongYuan LiuShu-Guang Lin Pharmacogenetics 12 February 2011 Pages: 581 - 590
Effects of multiple-dose pegylated interferon alfa-2b on the activity of drug-metabolizing enzymes in persons with chronic hepatitis C Samir K. GuptaKaren KolzDavid L. Cutler Pharmacokinetics and Disposition 16 December 2010 Pages: 591 - 599
Population pharmacokinetic study of cyclosporine in Chinese renal transplant recipients Bing ChenWeiXia ZhangWeiMin Cai Pharmacokinetics and Disposition 16 December 2010 Pages: 601 - 612
Risk of high-grade bleeding in patients with cancer treated with bevacizumab: a meta-analysis of randomized controlled trials Xiao Feng HangWen Sheng XuWu Ni Pharmacoepidemiology and Prescription 18 January 2011 Pages: 613 - 623
Adverse drug events in an intensive care unit of a university hospital Adriano Max Moreira ReisSilvia Helena De Bortoli Cassiani Pharmacoepidemiology and Prescription 19 January 2011 Pages: 625 - 632
Pharmacodynamic and pharmacokinetic drug interactions reported to VigiBase, the WHO global individual case safety report database Johanna StrandellStina Wahlin Pharmacoepidemiology and Prescription 21 January 2011 Pages: 633 - 641
Erratum to: Are results from pharmaceutical-company-sponsored studies available to the public? Rafael Dal-RéAlejandro PedromingoRafael Ortega Erratum 12 April 2011 Pages: 643 - 643
Author’s response to the Letter to the Editor of Tfelt-Hansen Ana MacedoMagí FarréJosep-E. Baños Letter to the Editors 21 November 2010 Pages: 645 - 646
Placebo response in migraine Peer Tfelt-Hansen Letter to the Editors 23 November 2010 Pages: 647 - 647
Safety surveillance of influenza A(H1N1)v monovalent vaccines during the 2009–2010 mass vaccination campaign in France Céline CailletGenevieve DurrieuThe French Network of Pharmacovigilance Centres Letter to the Editors 14 December 2010 Pages: 649 - 651
